STEPHANIE ATKINSON: Open Payments
NPI 1851350094 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,785 in 89 payments from 15 companies in 2025. Trend: 2023 $1,246 · 2024 $1,736 · 2025 $1,785
Food & beverage: $1,785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $707 |
| Janssen Biotech, Inc. | 10 | $182 |
| Madrigal Pharmaceuticals | 6 | $167 |
| GENZYME CORPORATION | 5 | $120 |
| Ardelyx, Inc. | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $108 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $99 |
| Lilly USA, LLC | 1 | $85 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
| Celltrion USA Inc. | 2 | $37 |
Products named: SKYRIZI, RINVOQ, TREMFYA, REZDIFFRA, DUPIXENT, IBSRELA, ENTYVIO, OMVOH.
Industry payments across MS — which companies pay providers there.
